Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis

Pediatric Pulmonology

Volumn 43, Issue 3, 2008, Pages 281-287

  Abdulhamid, I ^a,c   Beck, F W J ^a   Miliard, S ^b   Chen, X ^a   Prasad, A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Helen Devos Pediatric Rheumatology   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Cystic fibrosis; Cytokines; Respiratory tract infections; Zinc

Indexed keywords

ANTIBIOTIC AGENT; COPPER; CYTOKINE; GLUCONATE ZINC; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; ZINC;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHILD CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG USE; HUMAN; MONONUCLEAR CELL; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; CYTOKINES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; MINERALS; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; ZINC;

EID: 40649127001     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20771     Document Type: Article

References (47)

1. Rommens JM, Ianuzzi MC, Karem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Siga M, Buchwald M, Riordan JR, Tsui LC, Collins FS. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-1065.
2. Riordan JR, Rommens JM, Karem B, Alon N, Rozmahel R, Grzelczak Z, Zielinski J, Lok S, Plavsic N, Chon JL, Drumm MC, Ianuzzi MC, Collins FS, Tsui LC. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
3. Karem B, Rommens JM, Buchannan JA, Markiewicz D, Cox T, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
4. Easley D, Krebs N, Jefferson M, Miller L, Erskine J, Accurso F, Hambidge KM. Effect of pancreatic enzymes on zinc absorption in cystic fibrosis. J Pediatr Gastro Nutr 1998;26:136-139.
5. Krebs NF, Wescott JE, Arnold TD, Kluger BM, Accurso FJ, Miller LV, Hambidge KM. Abnormalities in zinc homeostasis in young infants with cystic fibrosis. Pediatr Res 2000;48:256-261.
6. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns IL, Castile R, Hiall P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW. Early pulmonary infections, inflammation and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001;32:356-366.
7. Chmiel JF, Berger M, Konstan MW. The role of inflammation in the pathology of CF lung disease. Clin Rev Allergy Immunol 2002;23:5-27.
8. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Resp Crit Care Med 2003;168:918-951.
9. Cantin AM. Potential for antioxidant therapy of cystic fibrosis. Curr Opin Pulm Med 2004;10:531-536.
10. Chmiel JF, Konstan MW. Anti-inflammatory medications for cystic fibrosis lung disease. Treat Respir Med 2005;4:255-273.
11. Zalewski PD. Zinc metabolism in the airway: basic mechanisms and drug targets. Curr Opin Pharmacol 2006;6:237-243.
12. Childers M, Eckel G, Himmel A, Caldwell J. A new model of cystic fibrosis pathology; Lack of transport of glutathione and its thiocyanate conjugates. Med Hypothesis 2007;68:101-112.
13. Zsembery A, Fortenberry JA, Liang L, Bebok Z, Tucker TA, Boyce AT, Braunstein GM, Welty E, Bell PD, Sorscher EJ, Clancy JP, Schwiebert EM. Extracellular zinc and ATP restore chloride secretion across cystic fibrosis airway epithelia by triggering calcium entry J. Biol Chem 2004;279:10720-10729.
14. Taylor CG, Bray TM. Effect of hyperoxia on oxygen free radical defense enzymes in the lung of zinc-deficient rats. J Nutr 1991;121:460-466.
15. Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, Bhan MK. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics 1998;102:1-5.
16. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH. Antioxidant effect of zinc in humans. Free Rad Biol Med 2004;37:1182-1190.
17. Prasad AS, Fitzgerald JT, Bao B, Beck FWJ, Chandraeskar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. Ann Int Med 2000;133:245-252.
18. Prasad AS, Beck FWJ, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ. Zinc supplementation decreases incidence of infection in the elderly: effect of zinc on the generation of cytokines and oxidative stress. Am J Clin Nutr 2007;85:837-844.
19. Akanli L, Lowenthal DB, Gjonaj S, Dozor AJ. Plasma and red blood cell zinc in cystic fibrosis. Pediatr Pulmonol 2003;25:2-7.
20. Safai-Kutti S, Selin E, Larsson S, Jagenburg R, Denfors I, Sten G, Kjellmer I. Zinc therapy in children with cystic fibrosis. Beitr Infusionsther 1991;27:104-114.
21. Mocchegiani E, Provinciali M, Di Stefano G, Nobilini A, Caramia G, Santarelli L, Tibaldi A, Fabris N. Role of the low zinc bioavailability on cellular immune effectiveness in cystic fibrosis. Clin Immunol Immunopathol 1995;75:214-224.
22. Beck FWJ, Li Y, Bao B, Prasad AS, Sarkar FH. Evidence for reprogramming global gene expression during zinc deficiency in the HUT-78 cell line. Nutrition 2006;22:1045-1056.
23. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry. 3rd edition. Philadelphia, PA: W.B. Saunders Co.; 1999.
24. Krebs NF, Sontag M, Accurso FJ, Hambidge JM. Low plasma zinc concentrations in young infants with cystic fibrosis. J Pediatr 1998;133:761-764.
25. Maqbool A, Schall JI, Zemel BS, Garcia-Espana JF, Stallings VA. Plasma zinc and growth status in preadolescent children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2006;43:95-101.
26. Navarro J, Dequilbet N. Depressed plasma vitamin A and retinol-binding protein in cystic fibrosis correlates with zinc deficiency. Am J Clin Nutr 1981;34:1439-1440.
27. Jacob RA, Sandstead HH, Solomons NW, Rieger C, Rothberg R. Zinc status and vitamin A transport in cystic fibrosis. Am J Clin Nutr 1978;31:638-644.
28. Neve J, Van Geffel R, Hanocq M, Molle L. Plasma erythrocyte zinc, copper and selenium in cystic fibrosis. Acta Paediatr Scand 1993;72:437-440.
29. Prasad AS, Meftah S, Abdallah J, Kaplan J, Brewer GJ, Dardenne M. Serum thymulin inhuman zinc deficiency. J Clin Invest 1986;82:1202-1210.
30. Hubeau C, Le Naour R, Abely M, Hinnrasky J, Guenounou M, Giallard D, Puchelle E. Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin Exp Immunol 2004;135:528-534.
31. Prasad AS, Beck FWJ, Kaplan J, Chandrasekar PH, Ortega J, Fitzgerald JT, Swerdlow P. Effect of zinc supplementation on the incidence of infections and hospital admissions in sickle cell disease (SCD). Am J Hematol 1999;61:194-202.
32. Bates CJ, Evans PH, Dardenne M, et al. A trial of zinac supplementation in young rural Gambian Children. Br J Nutr 1993;69:243-255.
33. Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics 2007;119:1120-1130.
34. Colombo C, Costantini D, Rocchi A, Cariani L, Garlaschi ML, Tirelli S, Calori G, Copreni E, Conese M. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Pediatr Pulmonol 2005;40:15-21.
35. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis. Pediatr Res 1993;34:159-161.
36. Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 1997;175:638-647.
37. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory response to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999;160:186-191.
38. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
39. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:1197-1204.
40. Brazova J, Sediva A, Pospisilova D, Vavravo V, Pohunek P, Macek M, Bartunkova J, Lauschmann H. Differential cytokine profile in children with cystic fibrosis. Clin Immunol 2005;115:210-215.
41. Shmarina GV, Pukhalsky AL, Kokarovtseva SN, Pukhalskya DA, Shabalova LA, Kapranov NI, Kashirskaja NJ. Tumor necrosis factor-α/interleukin-10 balance in normal and cystic fibrosis children. Mediators Inflamm 2001;10:191-197.
42. De Rose V, Ilova A, Messore B, Grosso B, Mollar C, Popzzi E. Circulating adhesion molecules in cystic fibrosis. Am J Respir Crit Care Med 1998;157:1234-1239.
43. Bao B, Prasad AS, Beck FWJ, Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 2003;285:E1095-E1102.
44. Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor-κ B in pulmonary diseases. Chest 2000;117:1482-1487.
45. Saadane A, Soltys J, Berger M. Role of IL-10 deficiency in excessive nuclear factor-kB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice. J Allergy Clin Immunol 2005;115: 405-411.
46. Kellerberger S, Gautschi I, Pfister Y, Schild L. Intracellular thiol-mediated modulation of epithelial sodium channel activity. J Biol Chem 2005;280:7739-7747.
47. Thelin WR, Boucher RC. The epithelium as a target for therapy in cystic fibrosis. Curr Opin Pharmacol 2007;7:1-6.